ERBB2 and neoplasm: Metformin treated HER2 CAR T cells showed increased proportions of Tscm and Tcm cells, along with enhanced anti-tumor capabilities, likely via activation of the AMPK–miR-107–Eomes–PD-1 pathway (256).